Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Opinion Off Script

The Future of Cardiothoracic Surgery, Too, Lies in Innovation

Friedhelm Beyersdorf, MD

May 13, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Michael O'Riordan

September 23, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

Michael O'Riordan

April 16, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

Advertisement

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

AHA Celebrates a Century by Looking Back, and Forward

The Future of Cardiothoracic Surgery, Too, Lies in Innovation

The Biggest News of 2023: TCTMD’s Top 10

AHA Scientific Statement Addresses Health Disparities in PAD

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

TCTMD’s Top 10 Most Popular Stories for February 2023

TCTMD’s Top 10 Most Popular Stories for July 2022

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

February 2022 News Roundup

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content